SCHEMBL29359062

SCHEMBL29359062

[O-][S+](c1ccc(Cl)cc1)c1cc(Cl)c(Cl)cc1Cl

nearest known ligand 0.36

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
LMNA P02545 1/20 0.33
CYP2A6 P11509 1/20 0.33
AHR P35869 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10539500 0.84 HSD17B10 (0.40) MEN1KMT2ALMNA
SCHEMBL9629161 0.84 CYP3A4 (0.40) MEN1KMT2ALMNA
SCHEMBL10536643 0.84 IDO1 (0.34)
SCHEMBL11659032 0.77 CYP3A4 (0.42) TP53MEN1KMT2A
SCHEMBL548628 0.77 LMNA (0.50) MEN1KMT2ALMNACYP2A6
SCHEMBL9637022 0.77 LMNA (0.50) MEN1KMT2ALMNACYP2A6
SCHEMBL9635796 0.77 LMNA (0.50) MEN1KMT2ALMNACYP2A6
SCHEMBL10537822 0.73 TSHR (0.41) TP53MEN1KMT2A
SCHEMBL9629034 0.73 TSHR (0.41) TP53MEN1KMT2ALMNA
SCHEMBL10536646 0.73 IDO1 (0.41) TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1082 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122037471-A Material for solving stress problem of non-excavation repair of pressure pipeline and application 成都龙之泉科技股份有限公司 2026-05-15 CN claimed
US-20260008854-A1 METHODS FOR VACCINATION OF A SUBJECT TREATED WITH AN FCRN ANTAGONIST argenx BV (BE) 2026-01-08 US claimed
WO-2025233685-A1 INTRAVENOUS FCRN ANTAGONIST FORMULATIONS AND METHODS OF USE THEREOF argenx BV (BE) 2025-11-13 WO claimed
US-20250195631-A1 ANTIGEN DELIVERING SALMONELLA FOR USE AS A TUMOR HOMING BEACON TO REFOCUS PREEXISTING, VACCINE GENERATED T CELLS TO COMBAT CANCER UNIVERSITY OF MASSACHUSETTS 2025-06-19 US claimed
CN-119955092-A Etchable adhesive composition cured at low temperature, preparation method and application thereof 上海邃铸科技有限公司 2025-05-09 CN claimed
CN-119570418-A High-viscosity epoxy resin adhesive and preparation method thereof 博罗县三通电子材料有限公司 2025-03-07 CN claimed
CN-119463770-A Moisture-heat resistant single-component mercaptan epoxy adhesive 苏州毫邦新材料有限公司 2025-02-18 CN claimed
EP-4499805-A1 ANTIGEN DELIVERING SALMONELLA FOR USE AS A TUMOR HOMING BEACON TO REFOCUS PREEXISTING, VACCINE GENERATED T CELLS TO COMBAT CANCER University Of Massachusetts (US) 2025-02-05 EP claimed
CN-119307067-A Multi-gradient composite prepreg and preparation method thereof 朗昇高新材料科技(天津)有限公司 2025-01-14 CN claimed
CN-117264544-B Photo-thermal dual-curing adhesive for electronic precision device and preparation method thereof 广东德聚技术股份有限公司 2024-12-03 CN claimed
CN-114262592-A Single-component low-temperature curing epoxy adhesive with high adhesive force on polyester material 深圳斯多福新材料科技有限公司 2022-04-01 CN claimed
CN-114214018-A Underfill adhesive for mini display screen 东莞市亚聚电子材料有限公司 2022-03-22 CN claimed
CN-114214019-A Preparation method of high-temperature and low-temperature resistant single-component adhesive 深圳斯多福新材料科技有限公司 2022-03-22 CN claimed
US-20220072117-A1 Dimethyl Fumarate and Vaccination Regimens BIOGEN MA INC. (US) 2022-03-10 US claimed
CN-114106757-A Low-precipitation single-component epoxy adhesive and preparation method and application thereof 上海昀通电子科技有限公司 2022-03-01 CN claimed
CN-111205810-B Photo-thermal dual-curing adhesive and preparation method thereof 烟台德邦科技股份有限公司 2022-02-11 CN claimed
CN-112080188-B Preparation method of water-based epoxy surface paint suitable for electrical equipment 苏州太湖电工新材料股份有限公司 2022-02-11 CN claimed
CN-113999637-A Single-component low-temperature epoxy adhesive and preparation method thereof 韦尔通(厦门)科技股份有限公司 2022-02-01 CN claimed
CN-113980582-A Light, heat and moisture curable adhesive and preparation method thereof 烟台德邦科技股份有限公司 2022-01-28 CN claimed
CN-113980624-A Low-viscosity epoxy potting material for silicon carbide power module packaging and preparation method and application thereof 湖南国芯半导体科技有限公司 2022-01-28 CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220072117-A1 Dimethyl Fumarate and Vaccination Regimens FH, HLA-DRB1, SDHB TP53 145/4885MEN1 455/4885KMT2A 417/4885
US-20260008854-A1 METHODS FOR VACCINATION OF A SUBJECT TREATED WITH AN FCRN ANTAGONIST FCGRT, FCGR3B, FCGR1A TP53 1449/4885MEN1 4260/4885KMT2A 1684/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.